Israeli Man Diagnosed With Rare Bone Cancer After Knee Pain Leads to Urgent Treatment

Oren Weiss, a 34-year-old DevOps engineer from Moshav Burgata, Israel, discovered he had a rare and aggressive bone cancer called osteosarcoma after experiencing severe knee pain during a trip to Europe in June 2023. Initially attributing the pain to an old military injury and previous knee surgery, Weiss sought medical advice upon returning to Israel. Persistent pain led to advanced imaging tests, which revealed the malignant tumor in his thigh bone.

Weiss was urgently referred to Dr. Israel Weiss at Beilinson Hospital, where the diagnosis was confirmed. Osteosarcoma is typically diagnosed in children and adolescents, making Weiss's case unusual due to his age. He underwent an intensive treatment regimen including six cycles of chemotherapy, biological therapy, and a complex surgery to remove the tumor and reconstruct his leg with a custom prosthesis. Dr. Israel Weiss emphasized the importance of complete tumor removal to prevent spread and highlighted advances in prosthetic technology that preserve limb function.

During his recovery, Weiss trained alongside soldiers wounded in recent conflicts, drawing strength from their resilience. Despite ongoing chronic pain and disability, he maintained his work routine at the technology company WIZ and committed to physical rehabilitation. Weiss and his wife, Yarden, faced additional challenges in starting a family, including a miscarriage at 21 weeks. After fertility treatments, they welcomed their son Omer, which Weiss described as "a victory of life over death."

Medical experts Dr. Israel Weiss and Dr. Idit Peretz from the Davidoff Center at Beilinson stressed the importance of awareness about sarcomas, especially among young active individuals. They urged people to seek medical evaluation for persistent pain without injury, pain at rest, swelling, redness, or systemic symptoms such as appetite loss. Weiss's experience underscores the need for vigilance and early diagnosis in rare cancers to improve outcomes.